Cargando…
High Plasma Lipid Levels Reduce Efficacy of Adenovirus-Mediated Gene Therapy
Adenoviruses are very efficient vectors for delivering therapeutic genes in preclinical and clinical trials. However, randomized controlled human trials have often been lacking clear clinically relevant results. We hypothesized that high lipid levels and specific lipoproteins could significantly dec...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428218/ https://www.ncbi.nlm.nih.gov/pubmed/28341860 http://dx.doi.org/10.1038/s41598-017-00376-5 |
_version_ | 1783235767033659392 |
---|---|
author | Kivelä, A. M. Huusko, J. Gurzeler, E. Laine, A. Dijkstra, M. H. Dragneva, G. Andersen, C. B. F. Moestrup, S. K. Ylä-Herttuala, S. |
author_facet | Kivelä, A. M. Huusko, J. Gurzeler, E. Laine, A. Dijkstra, M. H. Dragneva, G. Andersen, C. B. F. Moestrup, S. K. Ylä-Herttuala, S. |
author_sort | Kivelä, A. M. |
collection | PubMed |
description | Adenoviruses are very efficient vectors for delivering therapeutic genes in preclinical and clinical trials. However, randomized controlled human trials have often been lacking clear clinically relevant results. We hypothesized that high lipid levels and specific lipoproteins could significantly decrease adenoviral transduction efficiency in vivo. Here we demonstrate that mice on a high fat diet have lower transgene expression compared to mice on a regular chow. In addition, on a high fat diet, ApoE(−/−) mice have much higher plasma transgene levels compared to LDLR-deficient mice. We also found that specific lipoprotein receptors play an important role in adenoviral transduction. These findings suggest that high plasma lipid levels, especially apoE-containing lipoproteins, reduce efficacy of adenoviral transduction in mice, which implies that high cholesterol levels in humans could be protective against viral infections and also lead to insufficient transgene expression in clinical trials using adenoviral vectors. |
format | Online Article Text |
id | pubmed-5428218 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-54282182017-05-15 High Plasma Lipid Levels Reduce Efficacy of Adenovirus-Mediated Gene Therapy Kivelä, A. M. Huusko, J. Gurzeler, E. Laine, A. Dijkstra, M. H. Dragneva, G. Andersen, C. B. F. Moestrup, S. K. Ylä-Herttuala, S. Sci Rep Article Adenoviruses are very efficient vectors for delivering therapeutic genes in preclinical and clinical trials. However, randomized controlled human trials have often been lacking clear clinically relevant results. We hypothesized that high lipid levels and specific lipoproteins could significantly decrease adenoviral transduction efficiency in vivo. Here we demonstrate that mice on a high fat diet have lower transgene expression compared to mice on a regular chow. In addition, on a high fat diet, ApoE(−/−) mice have much higher plasma transgene levels compared to LDLR-deficient mice. We also found that specific lipoprotein receptors play an important role in adenoviral transduction. These findings suggest that high plasma lipid levels, especially apoE-containing lipoproteins, reduce efficacy of adenoviral transduction in mice, which implies that high cholesterol levels in humans could be protective against viral infections and also lead to insufficient transgene expression in clinical trials using adenoviral vectors. Nature Publishing Group UK 2017-03-24 /pmc/articles/PMC5428218/ /pubmed/28341860 http://dx.doi.org/10.1038/s41598-017-00376-5 Text en © The Author(s) 2017 This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Kivelä, A. M. Huusko, J. Gurzeler, E. Laine, A. Dijkstra, M. H. Dragneva, G. Andersen, C. B. F. Moestrup, S. K. Ylä-Herttuala, S. High Plasma Lipid Levels Reduce Efficacy of Adenovirus-Mediated Gene Therapy |
title | High Plasma Lipid Levels Reduce Efficacy of Adenovirus-Mediated Gene Therapy |
title_full | High Plasma Lipid Levels Reduce Efficacy of Adenovirus-Mediated Gene Therapy |
title_fullStr | High Plasma Lipid Levels Reduce Efficacy of Adenovirus-Mediated Gene Therapy |
title_full_unstemmed | High Plasma Lipid Levels Reduce Efficacy of Adenovirus-Mediated Gene Therapy |
title_short | High Plasma Lipid Levels Reduce Efficacy of Adenovirus-Mediated Gene Therapy |
title_sort | high plasma lipid levels reduce efficacy of adenovirus-mediated gene therapy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428218/ https://www.ncbi.nlm.nih.gov/pubmed/28341860 http://dx.doi.org/10.1038/s41598-017-00376-5 |
work_keys_str_mv | AT kivelaam highplasmalipidlevelsreduceefficacyofadenovirusmediatedgenetherapy AT huuskoj highplasmalipidlevelsreduceefficacyofadenovirusmediatedgenetherapy AT gurzelere highplasmalipidlevelsreduceefficacyofadenovirusmediatedgenetherapy AT lainea highplasmalipidlevelsreduceefficacyofadenovirusmediatedgenetherapy AT dijkstramh highplasmalipidlevelsreduceefficacyofadenovirusmediatedgenetherapy AT dragnevag highplasmalipidlevelsreduceefficacyofadenovirusmediatedgenetherapy AT andersencbf highplasmalipidlevelsreduceefficacyofadenovirusmediatedgenetherapy AT moestrupsk highplasmalipidlevelsreduceefficacyofadenovirusmediatedgenetherapy AT ylaherttualas highplasmalipidlevelsreduceefficacyofadenovirusmediatedgenetherapy |